Advair Diskus: Dual-Action Control for Asthma and COPD - Evidence-Based Review

Product Description Advair Diskus is a prescription-only inhalation device containing a fixed-dose combination of two active pharmaceutical ingredients: fluticasone propionate, a corticosteroid, and salmeterol xinafoate, a long-acting beta2-adrenergic agonist (LABA). It is delivered as a dry powder for oral inhalation. It is not a dietary supplement or an over-the-counter medical device; it is a potent medication classified as a controlled substance in many jurisdictions due to the salmeterol component. Its primary role is in the maintenance treatment of chronic respiratory conditions, specifically asthma and chronic obstructive pulmonary disease (COPD).